Collins Cooper C.

Collins Cooper C. is listed in filings as Director at TherapeuticsMD, Inc.. This profile follows SEC Form 4 activity through Nov 5, 2025, including purchase activity. Recent filings connect the profile to TherapeuticsMD, Inc. (TXMD). The current snapshot covers public activity from Aug 23, 2024 to Nov 5, 2025. Reported amounts are shown as $7.1K to $2.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.